-
HIV-1 Vif: counteracting innate antiretroviral defenses.
Howard Hughes Medical Institute and Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA. culle002@mc.duke.edu
PMID: 14565218 [PubMed - indexed for MEDLINE]
-
Cited by 4 PubMed Central articles
-
Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1.
Watashi K, Khan M, Yedavalli VR, Yeung ML, Strebel K, Jeang KT.
J Virol. 2008 Oct; 82(20):9928-36. Epub 2008 Aug 6.
[J Virol. 2008]
-
Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.
Iwatani Y, Takeuchi H, Strebel K, Levin JG.
J Virol. 2006 Jun; 80(12):5992-6002.
[J Virol. 2006]
-
Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification.
Simon V, Zennou V, Murray D, Huang Y, Ho DD, Bieniasz PD.
PLoS Pathog. 2005 Sep; 1(1):e6. Epub 2005 Jul 22.
[PLoS Pathog. 2005]
- » See all...